The following table summarizes the primary metabolic targets and effects
LiteratureThis section has been translated automatically
Specifically, these molecules have been associated with a high rate of eryptosis in CKD
Network-based drug repurposing has leveraged betweenness and closeness centrality to rank pathway significance and predict drug-disease associations 33,34 , while centrality metrics have also been used to examine disease co-occurrence and mechanistic overlaps 19,35
Flow cytometry analysis revealed optimized cell cycle progression, with increased cells at G1 stage and decreased cells at G2 stage following GHK-Cu-liposomes treatment
By digging into these mechanisms, were beginning to answer some of these questions, said co-corresponding author Andrew Lutas, Ph.D., an investigator at NIHs National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)